Palonosetron on days 1 and 5 versus granisetron daily (days 1-5) in germ cell tumour therapy

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: The control of chemotherapy-induced nausea and vomiting during bleomycin, etoposide, and cisplatin (BEP) treatment is important for maintaining treatment intensity. The effects of palonosetron and granisetron were compared in BEP chemotherapy. Patients and Methods: The administration of palonosetron on days 1 and 5 (Pal method) and granisetron daily (days 1-5, Gra method) were compared in terms of their efficacy and cost-effectiveness. Results: Additional rescue antiemetic agents were used in 15 of 32 and 30 of 30 cycles in the Pal and Gra method groups, respectively (p<0.05). The complete response rate, defined as no vomiting and no rescue agent usage, in each cycle, was 50% and 0% in the Pal and Gra method groups, respectively (p<0.05). The average cost of antiemetic agents in a cycle was 50,759 and 54,555 yen in the Pal and Gra method groups, respectively (p<0.05). Conclusion: The Pal method may be the standard method in BEP.

References Powered by Scopus

International germ cell consensus classification: A prognostic factor- based staging system for metastatic germ cell cancers

1938Citations
N/AReaders
Get full text

Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide

1136Citations
N/AReaders
Get full text

Antiemetics: American Society of Clinical Oncology clinical practice guideline update

468Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Antiemetic Efficacy and Safety of Palonosetron on Days 1 and 5 with Aprepitant and Dexamethasone during Bleomycin, Etoposide, and Cisplatin Chemotherapy in Patients with Germ Cell Tumor: A Prospective Study

0Citations
N/AReaders
Get full text

Procalcitonin in advanced urological cancer - bacterial versus non-bacterial infections: prospective cohort study

0Citations
N/AReaders
Get full text

Treatment at an Inexperienced Center Suggests Worse Prognosis of Metastatic Germ Cell Tumors

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Shimura, Y., Izumi, K., Itai, S., Iwamoto, H., Yaegashi, H., Suga, Y., … Yoshimichi, S. A. I. (2019). Palonosetron on days 1 and 5 versus granisetron daily (days 1-5) in germ cell tumour therapy. In Vivo, 33(2), 643–647. https://doi.org/10.21873/invivo.11522

Readers' Seniority

Tooltip

Professor / Associate Prof. 1

25%

Lecturer / Post doc 1

25%

PhD / Post grad / Masters / Doc 1

25%

Researcher 1

25%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

50%

Agricultural and Biological Sciences 1

25%

Nursing and Health Professions 1

25%

Save time finding and organizing research with Mendeley

Sign up for free